Industry Seeks Flexibility, Clarity On US FDA Clinical Trial Diversity Action Plan Requirements

 
• By Sue Sutter
  
Flexibility ribbon
Industry wants FDA flexibility on setting enrollment goals for diversity action plans. • Source: Shutterstock

More from Clinical Trials

More from R&D